[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 28, Issue 3 (August-September 2024) ::
Feyz Med Sci J 2024, 28(3): 324-334 Back to browse issues page
Aedes mosquito and dengue fever in Iran and worldwide: medical significance, prevention, and control
Reza Hosseiniara , Vahid Mohammadi-Shahrokhi , Sadegh Zarei , Rouhullah Dehghani *
Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, Iran & Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, Iran , dehghani37@yahoo.com
Abstract:   (2734 Views)
Dengue fever, an arboviral disease primarily transmitted by Aedes mosquitoes, poses a significant public health concern globally. Key vectors, such as Aedes aegypti, Aedes albopictus and Aedes cinereus, are widely distributed in tropical and subtropical regions, affecting over 140 countries. These species are also found in Iran, particularly in the southern, southeastern, and northern regions.
Diagnosing dengue fever presents challenges, including differentiating it from other febrile illnesses and recognizing early warning signs of severe dengue. Symptoms typically include acute fever, warning signs of severe illness, and potential complications. The clinical progression of dengue includes three phases: the febrile phase, critical phase, and recovery phase. A comprehensive understanding of clinical manifestations, prognostic indicators, diagnostic algorithms, and laboratory methods is crucial for accurate diagnosis, risk assessment, and effective disease management. Given the absence of specific antiviral treatments or vaccines for dengue, supportive care and symptomatic treatment remain essential.
This narrative review discusses the management of dengue fever, focusing on supportive care, fluid management, antipyretic and analgesic medications, and antiviral treatments. Additionally, it reviews potential future treatment strategies and emphasizes the importance of early diagnosis and prompt medical intervention in improving patient outcomes. The study also explores immunological targets, vaccine platforms, clinical trials, and future prospects for dengue vaccination. Furthermore, it presents prevention strategies targeting Aedes mosquitoes and outlines the challenges that lie ahead.
By adopting a comprehensive and interdisciplinary approach, we can pave the way for advancements in the prevention and control of dengue fever related to Aedes mosquito transmission. Continued research efforts, innovative collaborations, and public health training are vital to combat dengue fever and reduce its burden on affected populations worldwide.
Keywords: Aedes mosquito, Dengue fever, Dengue virus, Iran
Full-Text [PDF 444 kb]   (2391 Downloads)    
Type of Study: Review | Subject: medicine, paraclinic
Received: 2024/06/4 | Revised: 2024/09/8 | Accepted: 2024/08/20 | Published: 2024/08/31
References
1. Samsudin NA, Othman H, Siau CS, Zaini ZI. Exploring community needs in combating aedes mosquitoes and dengue fever: a study with urban community in the recurrent hotspot area. BMC Public Health. 2024 Jun 20;24(1):1651.
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF. The global distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504-7.
3. Wahala WM, De Silva AM. The human antibody response to dengue virus infection. Viruses. 2011 Nov 25;3(12):2374-95.
4. Sirisopa P, Sukkanon C, Bangs MJ, Nakasathien S, Hii J, Grieco JP, Achee NL, Manguin S, Chareonviriyaphap T. Scientific achievements and reflections after 20 years of vector biology and control research at the Pu Teuy mosquito field research station, Thailand. Malaria Journal. 2022 Feb 14;21(1):44.
5. Nebbak A, Monteil-Bouchard S, Berenger JM, Almeras L, Parola P, Desnues C. Virome diversity among mosquito populations in a sub-urban region of Marseille, France. Viruses. 2021 Apr 27;13(5):768.
6. Pereira LP, Araruna FB, Araruna FO, Brito MC, Silveira DP, Ribeiro EC, Borges AC, de Andrade MS, Leal ER, Coutinho DF. Molecular Aspects of Species of the Genus Aedes with Epidemiological Importance. Mosquito-borne Diseases: Implications for Public Health. 2018:305-21.
7. Dorzaban H, Soltani A, Alipour H, Hatami J, Jaberhashemi SA, Shahriari-Namadi M, et al. Mosquito surveillance and the first record of morphological and molecular-based identification of invasive species Aedes (Stegomyia) aegypti (Diptera: Culicidae), southern Iran. Exp Parasitol. 2022; 236: 108235.
8. Harbach RE, Dallimore T, Briscoe AG, Culverwell CL, Vaux AG, Medlock JM. Aedes nigrinus (Eckstein, 1918)(Diptera, Culicidae), a new country record for England, contrasted with Aedes sticticus (Meigen, 1838). ZooKeys. 2017(671):119.
9. Russell RC, Currie BJ, Lindsay MD, Mackenzie JS, Ritchie SA, Whelan PI. Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Australia. 2009; 190(5): 265-8.
10. Sroute L, Byrd BD, Huffman SW. Classification of mosquitoes with infrared spectroscopy and partial least squares-discriminant analysis. Appl Spectrosc. 2020;74(8):900-12.
11. Sahu SS, Gunasekaran K, Jambulingam P. Bionomics of Anopheles minimus and An. fluviatilis (Diptera: Culicidae) in east-central India, endemic for falciparum malaria: human landing rates, host feeding, and parity. J Med Entomol. 2009;46(5):1045-51.
12. Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. New England Journal of Medicine. 2012 Apr 12;366(15):1423-32.
13. https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON518 [Last access: 15 augut 2024]
14. Cleri DJ, Ricketti AJ, Porwancher RB, Ramos-Bonner LS, Vernaleo JR. Viral hemorrhagic fevers: current status of endemic disease and strategies for control. Infect Dis Clin. 2006 Jun 1;20(2):359-93.
15. Dehghani R, Kassiri H. A review on epidemiology of dengue viral infection as an emerging disease. Res J Pharmacy Technol. 2021; 14(4): 2296-301.
16. Lankarani KB, Alavian SM, Peymani P. Health in the Islamic Republic of Iran, challenges and progresses. Med J Islamic Republic Iran. 2013; 27(1): 42.
17. Doosti S, Yaghoobi-Ershadi MR, Schaffner F, Moosa-Kazemi SH, Akbarzadeh K, Gooya MM, et al. Mosquito surveillance and the first record of the invasive mosquito species Aedes (Stegomyia) albopictus (Skuse)(Diptera: Culicidae) in southern Iran. Iran J Public Health. 2016; 45(8): 1064.
18. Azari-Hamidian S, Norouzi B, Harbach RE. A detailed review of the mosquitoes (Diptera: Culicidae) of Iran and their medical and veterinary importance. Acta Tropica. 2019; 194: 106-22.
19. Dehghani R, Kassiri H. A review on epidemiology of dengue viral infection as an emerging disease. Res J Pharmacy Technol. 2021; 14(4): 2296-301.
20. Guyatt HL, Ochola SA, Snow RW. Too poor to pay: charging for insecticide‐treated bednets in highland Kenya. Tropical Med Int Health. 2002; 7(10): 846-50.
21. Liu Z, Zhang Q, Li L, He J, Guo J, Wang Z, et al. The effect of temperature on dengue virus transmission by Aedes mosquitoes. Front Cell Infect Microbiol. 2023; 13: 1242173.
22. Kabir MR, Rahman N, Iqbal A, Azad F, Tithi SH, Uddin MH, et al. Socio-demographic, environmental and life style factors on the dengue epidemic in Noakhali District, Bangladesh: Evidence from recent outbreak. J Communicable Dis. 2020;52(4):57-65.
23. Kwon JW, Chun H, Cho SI. A closer look at the increase in suicide rates in South Korea from 1986–2005. BMC Public Health. 2009; 9: 1-9.
24. Brandelli CL, Cargnin ST, Willers DM, Oliveira KR, Tasca T. Comparison between spontaneous sedimentation method and Paratest® for the diagnosis of intestinal parasitic infections. Trans R Soc Trop Med Hyg. 2011; 105(10): 604-6.
25. Gibson J, Schechter-Perkins EM, Mitchell P, Mace S, Tian Y, Williams K, Luo R, Yen-Lieberman B. Multi-center evaluation of the cobas® Liat® Influenza A/B & RSV assay for rapid point of care diagnosis. J Clin Virol. 2017; 95:5-9.
26. Ramírez-Toloza G, Aguilar-Guzmán L, Valck C, Ferreira VP, Ferreira A. The interactions of parasite calreticulin with initial complement components: consequences in immunity and virulence. Front Immunol. 2020; 11: 1561.
27. Htun TP, Xiong Z, Pang J. Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis. Emerg Microbes Infect. 2021; 10(1): 1116-28.
28. Thomas SJ, Rothman AL, Srikiatkhachorn A, Kalayanarooj S. Dengue virus infection: clinical manifestations and diagnosis. Waltham, MA, USA: UpToDate. 2018.
29. Ishiwada N, Fukasawa C, Inami Y, Hishiki H, Takeda N, Sugita K, et al. Quantitative measurements of Hemophilus influenzae type b capsular polysaccharide antibodies in Japanese children. Pediatr Int. 2007; 49(6): 864-8.
30. Kalayanarooj S. Clinical manifestations and management of dengue/DHF/DSS. Tropical Med Health. 2011; 39(4SUPPLEMENT): S83-7.
31. Nowotny N, Kolodziejek J. Demonstration of borna disease virus nucleic acid in a patient with chronic fatigue syndrome. J Infect Dis. 2000; 181(5): 1860-1.
32. Lee IK, Liu JW, Yang KD. Fatal dengue hemorrhagic fever in adults: emphasizing the evolutionary pre-fatal clinical and laboratory manifestations. PLoS Neglected Tropical Diseases. 2012; 6(2): e1532.
33. Belaunzaran-Zamudio PF, Ortega-Villa AM, Mimenza-Alvarado AJ, Guerra-De-Blas PD, Aguilar-Navarro SG, Sepulveda-Delgado J, et al. Comparison of the impact of zika and dengue virus infection, and other acute illnesses of unidentified origin on cognitive functions in a prospective cohort in Chiapas Mexico. Front Neurol. 2021; 12: 631801.
34. Ou J, Chen R, Yan Z, Ou S, Dong N, Lu G, et al. Codon usage bias of H3N8 equine influenza virus-An evolutionary perspective. J Infect. 2020;80(6):671-93.
35. Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010; 67: 2773-86.
36. Seema, Jain SK. Molecular mechanism of pathogenesis of dengue virus: entry and fusion with target cell. Indian J Clin Biochem. 2005; 20:92-103.
37. Drancourt M, Raoult D. Palaeomicrobiology: current issues and perspectives. Nat Rev Microbiol. 2005; 3(1): 23-35.
38. Ayukekbong JA. Dengue virus in Nigeria: current status and future perspective. Hosts Viruses. 2014; 1(4):106.
39. Pylro VS, Mui TS, Rodrigues JL, Andreote FD, Roesch LF. A step forward to empower global microbiome research through local leadership. Trends Microbiol. 2016; 24(10): 767-71.
40. Di Rosa F. Maintenance of memory T cells in the bone marrow: survival or homeostatic proliferation?. Nat Rev Immunol. 2016; 16(4):271-.
41. Vödrös D, Tscherning-Casper C, Navea L, Schols D, De Clercq E, Fenyö EM. Quantitative evaluation of HIV-1 coreceptor use in the GHOST (3) cell assay. Virology. 2001; 291(1):1-1.
42. Gan ES, Ting DH, Chan KR. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis. Expert Rev Anti Ther. 2017; 15(2):111-9.
43. Testa JS, Shetty V, Sinnathamby G, Nickens Z, Hafner J, Kamal S, et al. Conserved MHC class I–presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-Cell response. J Infect Dis. 2012; 205(4):647-55.
44. Wilder-Smith A. Dengue vaccine development: challenges and prospects. Curr Opinion Infect Dis. 2022; 35(5): 390-6.
45. Deng SQ, Yang X, Wei Y, Chen JT, Wang XJ, Peng HJ. A review on dengue vaccine development. Vaccines. 2020; 8(1):63.
46. Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. The Lancet. 2014; 384(9951):1358-65.
47. Xu B, Tewari P, Thein TL, Sin LY, Lye DC, Chia PY, et al. Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects. J Med Virol. 2024;96(6):e29726.
48. Rajapakse S, Rodrigo C, Rajapakse A. Treatment of dengue fever. Infect Drug Resistance. 2012:103-12.
49. Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbial Rev. 2009 Oct;22(4):564-81.
50. Rather IA, Parray HA, Lone JB, Paek WK, Lim J, Bajpai VK, et al. Prevention and control strategies to counter dengue virus infection. Frontiers in cellular and Infect Microbiol. 2017;7:336.
51. Tayal A, Kabra SK, Lodha R. Management of dengue: an updated review. Indian J Pediatr. 2023;90(2):168-77.
52. Vanlerberghe VE, Toledo ME, Rodriguez M, Gomez D, Baly A, Benitez JR, et al. Community involvement in dengue vector control: cluster randomised trial. Bmj. 2009;338.
53. Jing Q, Wang M. Dengue epidemiology. Global Health J. 2019;3(2):37-45.
54. Gunn JK, Ernst KC, Center KE, Bischoff K, Nuñez AV, Huynh M, et al. Current strategies and successes in engaging women in vector control: a systematic review. BMJ Global Health. 2018;3(1):e000366.
55. Khoshdel-Nezamiha F, Vatandoost H, Azari-Hamidian S, Bavani MM, Dabiri F, Entezar-Mahdi R, et al. Fauna and larval habitats of mosquitoes (Diptera: Culicidae) of West Azerbaijan Province, northwestern Iran. J Arthropod-borne Dis. 2014;8(2):163.
56. Yaghoobi-Ershadi MR, Doosti S, Schaffner F, Moosa-Kazemi SH, Akbarzadeh K, Yaghoobi-Ershadi N. Morphological studies on adult mosquitoes (Diptera: Culicidae) and first report of the potential Zika virus vector Aedes (Stegomyia) unilineatus (Theobald, 1906) in Iran. Bulletin de la Société de Pathologie exotique. 2017;110(2):116.
57. Azari-Hamidian S. Checklist of Iranian mosquitoes (diptera: Culicidae). J Vector Ecol. 2007;32(2):235-42.
58. Nikookar SH, Maleki A, Fazeli-Dinan M, Shabani Kordshouli R, Enayati A. Entomological surveillance of the invasive aedes species at higher-priority entry points in Northern Iran: Exploratory report on a field study. JMIR Public Health and Surveillance. 2022;8(10):e38647.
59. Guha-Sapir D, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerging Themes in Epidemiol. 2005;2:1-0.
60. Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008;92(6):1377-90.
61. Zara AL, Santos SM, Fernandes-Oliveira ES, Carvalho RG, Coelho GE. Aedes aegypti control strategies: a review. Epidemiologia e Serviços de Saúde. 2016;25:391-404.
62. Kalluri S, Gilruth P, Rogers D, Szczur M. Surveillance of arthropod vector-borne infectious diseases using remote sensing techniques: a review. PLoS pathogens. 2007;3(10):e116.
63. Pinto SB, Riback TI, Sylvestre G, Costa G, Peixoto J, Dias FB, et al. Effectiveness of Wolbachia-infected mosquito deployments in reducing the incidence of dengue and other Aedes-borne diseases in Niterói, Brazil: A quasi-experimental study. PLoS neglected tropical diseases. 2021;15(7):e0009556.
64. Khormi HM, Kumar L. Climate change and the potential global distribution of Aedes aegypti: spatial modelling using geographical information system and CLIMEX. Geospatial Health. 2014;8(2):405-15.
65. Abílio AP, Abudasse G, Kampango A, Candrinho B, Sitoi S, Luciano J, et al. Distribution and breeding sites of Aedes aegypti and Aedes albopictus in 32 urban/peri-urban districts of Mozambique: implication for assessing the risk of arbovirus outbreaks. PLoS Neglected Tropical Dis. 2018;12(9):e0006692.
66. Hossain MJ, Das M, Islam MW, Shahjahan M, Ferdous J. Community engagement and social participation in dengue prevention: A cross‐sectional study in Dhaka City. Health Sci Reports. 2024;7(4):e2022.
67. Li Y, Kamara F, Zhou G, Puthiyakunnon S, Li C, Liu Y, et al. Urbanization increases Aedes albopictus larval habitats and accelerates mosquito development and survivorship. PLoS Neglected Tropical Dis. 2014; 8(11):e3301.
68. Deng HM, Romero N, Allard N, Rowe S, Yussf N, Cowie B. Uptake of perinatal immunoprophylaxis for infants born to women with a record of hepatitis B in Victoria (2009–2017). Vaccine. 2023;41(10):1726-34.
69. Qsim M, Ashfaq UA, Yousaf MZ, Masoud MS, Rasul I, Noor N, et al. Genetically modified Aedes aegypti to control dengue: a review. Critical Reviews™ in Eukaryotic Gene Expression. 2017;27(4).
70. Liu XL, Zhao C. A converging reputation ranking iteration method via the eigenvector. Plos one. 2022; 17(10): e0274567.
71. Goiri F, González MA, Cevidanes A, Barandika JF, García-Peréz AL. Mosquitoes in urban green spaces and cemeteries in northern Spain. Parasites Vectors. 2024;17(1):168.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hosseiniara R, Mohammadi-Shahrokhi V, Zarei S, Dehghani R. Aedes mosquito and dengue fever in Iran and worldwide: medical significance, prevention, and control. Feyz Med Sci J 2024; 28 (3) :324-334
URL: http://feyz.kaums.ac.ir/article-1-5216-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 28, Issue 3 (August-September 2024) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 45 queries by YEKTAWEB 4660